Journals / Hand and Microsurgery / 2020 / Cilt: 9 - Sayı: 1

Comparative outcomes of platelet rich plasma, autologous blood and corticosteroid injections in the treatment of lateral epicondylitis

Pages
20–26
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Assessments performed by a blind evaluator by visual analog scale (VAS), presence of tenderness,QuickDASH scores, grip strength measurements in pre-injection period and in post-injection first, third and sixth months.Statistical analyses performed in SPSS 21 software by Pearson’s chi-squared, Anova, Kruskar Wallis and McNemar tests.Results: Changes of VAS and QuickDASH scores in each group were significant according to pre-injection and post-injectionfirst, third, sixth month evaluations (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Lateral epicondylitis is a disorder in which the dominant extremity is usually affected, and its prevalence rangesbetween 1% and 3% in the general population.
📊
Key Findings & Data:It appears to be more common and severe in women between ages 30and 60.
💡
Conclusion & Impact:Assessments performed by a blind evaluator by visual analog scale (VAS), presence of tenderness,QuickDASH scores, grip strength measurements in pre-injection period and in post-injection first, third and sixth months.Statistical analyses performed in SPSS 21 software by Pearson’s chi-squared, Anova, Kruskar Wallis and McNemar tests.Results: Changes of VAS and QuickDASH scores in each group were significant according to pre-injection and post-injectionfirst, third, sixth month evaluations (p
🔬Design:Research Article
📍Scope:2011 Verileri
⚙️Variables:Domain Parameters

Abstract

Objectives: Lateral epicondylitis is a disorder in which the dominant extremity is usually affected, and its prevalence rangesbetween 1% and 3% in the general population. It appears to be more common and severe in women between ages 30and 60. Platelet rich plasma (PRP), autologous blood and corticosteroid injections are widely applied treatment modalitieswith various success rates. We aimed to investigate clinical outcomes of these three injection techniques. Study Design isProspective randomized clinical trial.Methods: Fifty two patients (19 men, 33 women) whom were diagnosed lateral epicondylitis between the years 2011 and2013, with a mean age 43,7years (min 18, max 62) were randomized into three groups according to application order. Eachgroup received one of the injection treatments: PRP, autologous blood or corticosteroid. Comparative clinical outcomesevaluated prospectively. Assessments performed by a blind evaluator by visual analog scale (VAS), presence of tenderness,QuickDASH scores, grip strength measurements in pre-injection period and in post-injection first, third and sixth months.Statistical analyses performed in SPSS 21 software by Pearson’s chi-squared, Anova, Kruskar Wallis and McNemar tests.Results: Changes of VAS and QuickDASH scores in each group were significant according to pre-injection and post-injectionfirst, third, sixth month evaluations (p

🔖

Cite This Article

GÜNAY, H., KÜÇÜK, L., KARAHAN, H. G., COŞKUNOL, E., EYCEYURT, R. S. (2022). Comparative outcomes of platelet rich plasma, autologous blood and corticosteroid injections in the treatment of lateral epicondylitis. Hand and Microsurgery, Cilt: 9 - Sayı: 1, 20–26. https://ajindex.com/articles/533874

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Martinez-Silvestrini JA, Newcomer KL, Gay RE, Schaefer MP, Kortebein P, Arendt KW. Chronic lateral epicondylitis: comparative effectiveness of a home exercise program including stretching alone versus stretching supplemented with eccentric or concentric strengthening. J Hand Ther 2005;18:411-9
  2. Waugh EJ, Jaglal SB, Davis AM, Tomlinson G, Verrier MC. Factors associated with prognosis of lateral epicondylitis after 8 weeks of physical therapy. Arch Phys Med Rehab 2004;85:308-18
  3. Borkholder CD, Hill VA, Fess EE. The efficacy of splinting for lateral epicondylitis: a systematic review. J Hand Therapy 2004;17:181-99
  4. Sevier TL, Wilson JK. Treating lateral epicondylitis. Sports Med 1999;28:375-80
  5. Fairbank SM, Corlett RJ. The role of the extensor digitorum communis muscle in lateral epicondylitis. J Hand Surg Br 2002;27:405-9
  6. Binder AI. Corticosteroid InjectionTherapy. In: Isenberg DA,Maddison PJ, Woo P, Glass D, Breedveld FC. Oxford Textbook of Rheumatology. Oxford University Pres, 2004:1228-1235
  7. Devor M, Govrin-Lippmann R, Raber P. Corticosteroids suppress ectopic neural discharge originating in experimental neuromas. Pain 1985;22:127-37
  8. Altay T, Günal I,Öztürk H. Local injection treatment for lateral epicondylitis. Clin Orthop Relat Res 2002;398:127-30
  9. Saartok T, Eriksson E. Randomized trial of oral naproxen or local injection of betamethasone in lateral epicondylitis of the humerus. Orthopedics 1986;9:191-4
  10. Krogh TP, Bartels EM, Ellingsen T, Stengaard-Pedersen K, Buchbinder R, Fredberg U, et al. Comparative Effectiveness of Injection Therapies in Lateral Epicondylitis A Systematic Review and Network Meta-analysis of randomized controlled trials. Am J Sports Med 2013;41:1435-46
  11. Rabago D, Best TM, Zgierska AE, Zeisig E, Ryan M, Crane DA. Systematic review of four injection therapies for lateral epicondylosis: prolotherapy, polidocanol, whole blood and platelet-rich plasma. Br J Sports Med 2009;43:471-81
  12. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dentistry 2001;10:225-8
  13. Weibrich G, Kleis WK, Hafner G, Hitzler WE. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Cranio-Maxillofacial Surg 2002;30:97-102
  14. Yoshida R, Cheng M, Murray MM. Increasing platelet concentration in platelet-rich plasma in hibits anterior cruciate ligament cell function in three-dimensionalculture. J Orthop Res 2014;32:291-5
  15. Peerbooms JC, Slui